Link Biologics

About

Link Biologics is a Manchester-based research company developing protein therapeutics for inflammatory and degenerative diseases.

The company focuses on TSG-6, an endogenous human protein with tissue-protective and anti-inflammatory properties, creating novel biologics that modulate multiple disease pathways rather than targeting single mechanisms.

The company's lead programmes are directed at Dry Eye Disease and Wet Age-related Macular Degeneration, conditions with significant unmet clinical needs. Link Biologics' approach combines anti-inflammatory, tissue-protective and tissue-reparative properties in a single therapeutic platform designed to fine-tune biological pathways and promote tissue repair.

Common questions

Where is Link Biologics based?

Link Biologics is based at Manchester, Greater Manchester.

What does Link Biologics do?

Link Biologics is a Manchester research company developing protein biologics based on TSG-6 to treat inflammatory and degenerative diseases including dry eye disease and age-related macular degeneration.

What sector does Link Biologics work in?

Link Biologics works in the Research sector.

How can I contact Link Biologics?

You can contact Link Biologics by email at anthony.day@manchester.ac.uk or through its website at https://linkbiologics.co.uk.